Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein.

MLA

Lu, Xingxing, et al. “Silencing AHNAK Promotes Nasopharyngeal Carcinoma Progression by Upregulating the ANXA2 Protein.” Cellular Oncology (2211-3428), vol. 47, no. 3, June 2024, pp. 833–50. EBSCOhost, https://doi.org/10.1007/s13402-023-00898-3.

APA

Lu, X., Mei, Y., Fan, C., Chen, P., Li, X., Zeng, Z., Li, G., Xiong, W., Xiang, B., & Yi, M. (2024). Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein. Cellular Oncology (2211-3428), 47(3), 833–850. https://doi.org/10.1007/s13402-023-00898-3

Chicago

Lu, Xingxing, Yan Mei, Chunmei Fan, Pan Chen, Xiayu Li, Zhaoyang Zeng, Guiyuan Li, Wei Xiong, Bo Xiang, and Mei Yi. 2024. “Silencing AHNAK Promotes Nasopharyngeal Carcinoma Progression by Upregulating the ANXA2 Protein.” Cellular Oncology (2211-3428) 47 (3): 833–50. doi:10.1007/s13402-023-00898-3.